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Abstract
Background: Interleukin (IL)-8 is the key agent for initiating an inflammatory response to infection with Helicobacter
pylori. Some strains of Lactobacillus spp. are known to colonize the stomach and suppress inflammation caused by
H. pylori. In this study, we characterized two gastric-derived lactobacilli, Lactobacillus salivarius (LS) strains B37 and
B60, capable of inhibiting H. pylori-induced IL-8 production by gastric epithelial cells.
Results: Conditioned media from LS-B37 and LS-B60 suppressed H. pylori-induced IL-8 production and mRNA
expression from AGS cells without inhibiting H. pylori growth. These conditioned media suppressed the activation
of NF-κB but did not suppress c-Jun activation. IL-8 inhibitory substances in conditioned media of LS-B37 and LS-
B60 are heat-stable and larger than 100 kDa in size. The inhibitory activity of LS-B37 was abolished when the
conditioned medium was treated with α-amylase but still remained when treated with either proteinase K, trypsin,
lipase or lysozyme. The activity of LS-B60 was abolished when the conditioned medium was treated with either
amylase or proteinase K but still remained when treated with lysozyme. Treatment with lipase and trypsin also
significantly affected the inhibitory activity of LS-B60 although the conditioned medium retained IL-8 suppression
statistically different from media control.
Conclusions: These results suggest that L. salivarius strains B37 and B60 produce different immunomodulatory
factors capable of suppressing H. pylori-induced IL-8 production from gastric epithelial cells. Our results suggest that
the large, heat-stable immunomodulatory substance(s) present in the LCM of LS-B37 is a polysaccharide, while the
one(s) of LS-B60 is either complex consisting of components of polysaccharide, lipid and protein or includes
multiple components such as glycoprotein and lipoprotein.
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Background
Helicobacter pylori is a well-known gastric pathogen
which causes gastroduodenal inflammation, peptic ulcer-
ation and gastric cancer [1, 2]. H. pylori infection
induces the production of pro-inflammatory cytokines
and chemokines such as interleukin (IL)-1β, IL-6, IL-8,
IL-23 and tumor necrosis factor (TNF)-α [3–5] resulting
in gastric inflammation characterized by the infiltration
of plasma cells, lymphocytes, neutrophils, and mono-
cytes within gastric mucosa [5, 6]. IL-8 secreted by
gastric epithelial cells is a potent neutrophil-activating
and chemotactic agent [7, 8] which plays a major role in
triggering the mucosal inflammation caused by H. pylori
[9–13]. Increased levels of IL-8 in gastric juice and
biopsy samples have been reported in patients with H.
pylori infection [10, 11]. In addition, the levels of IL-8
mRNA in the gastric mucosa of H. pylori-infected
patients correlate significantly with the severity of gastri-
tis [14, 15] and the risk of gastric cancer [16].* Correspondence: somying.T@chula.ac.th4Department of Microbiology, Faculty of Medicine, Chulalongkorn University,
Bangkok 10330, Thailand
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Symptomatic subjects diagnosed with H. pylori infec-
tion generally receive eradication therapy. However,
bacterial resistance to antibiotics and side effects which
contribute to poor patient compliance result in subopti-
mal eradication rates [17, 18]. Probiotics have been
shown to confer beneficial effects and are recommended
as an adjunct in the treatment of H. pylori [18, 19].
Suppression of pro-inflammatory cytokine secretion by
gastric epithelial cells is a mechanism of probiotic action
which has been shown by numerous reports [20, 21] and
considered as an approach to prevent gastric cancer
[22]. L. salivarius UCC118 inhibited H. pylori-induced
IL-8 production of AGS gastric epithelial cell by de-
creasing the function of the Cag secretion system [23].
L. acidophilus LA5® was shown to reduce IL-8 produc-
tion induced by H. pylori in MKN45 gastric epithelial
cells by inactivating the Smad7 and nuclear factor-
kappa B (NF-κB) pathways [24]. Moreover, L. gasseri
OLL2716 (LG21) was found to suppress H. pylori-in-
duced IL-8 production in MKN45 gastric epithelial cells
and decrease the level of IL-8 in the gastric mucosa of
H. pylori-infected patients [25]. We previously reported
eight isolates of Lactobacillus spp. which inhibited IL-8
secretion from H. pylori-infected AGS cells [26]. Among
these lactobacilli, L. salivarius B101, L. rhamnosus B103
and L. plantarum XB7 suppressed IL-8 mRNA expres-
sion and the activation of NF-κB whereas L. plantarum
XB7 also suppressed c-Jun activation. L. salivarius B37,
L. salivarius B60 and the other three strains inhibited
the secretion of IL-8 but did not interfere with IL-8 gene
transcription after co-culture for 4 h with AGS cells.
In this study, we characterized the mechanism by
which the previously identified L. salivarius B37 and
B60 strains suppress IL-8 production from H. pylori-in-
duced gastric epithelial cells. We hypothesized that L.
salivarius B37 and B60 may suppress IL-8 gene expres-
sion at other time points or affect IL-8 production post-
transcriptionally or post-translationally. The results of
this present study demonstrated that L. salivarius B37
and L. salivarius B60 produce distinct active compo-
nents that inhibit NF-κB activation and suppress down-
stream transcription of H. pylori-induced IL-8 mRNA.
Results
Gastric-derived L. salivarius strains B37 and B60 suppress
IL-8 production in H. pylori-induced AGS cells
L. salivarius B37 (LS-B37) and L. salivarius B60 (LS-
B60) are different strains as determined by random
amplified polymorphic DNA (RAPD) and repetitive-
sequence-based PCR (rep-PCR) fingerprinting (data not
shown). L. salivarius B78 (LS-B78), which does not
suppress IL-8, was included as a negative control.
Immunomodulatory activity of substances from Lacto-
bacillus conditioned media (LCM) was investigated by
co-incubation with AGS cells either alone or in combin-
ation with viable H. pylori ATCC 43504. LCM of both
LS-B37 and LS-B60 significantly (p < 0.001) suppressed
IL-8 production in H. pylori-stimulated AGS cells,
where LCM of LS-B78 did not suppress IL-8 production
as expected (Fig. 1, Additional file 1). Trypan blue dye
exclusion (>90 %, data not shown) indicated that IL-8
suppression by LS-B37 and LS-B60 was not due to cyto-
toxicity on AGS cells. LCM from LS-B37 and LS-B60
did not stimulate IL-8 production when co-incubated with
AGS cells in the absence of H. pylori (Fig. 1, Additional
file 1). In addition, 5 % v/v LCM in RPMI medium did not
inhibit the growth of H. pylori (data not shown).
Secreted factors from L. salivarius strains B37 and B60
diminished IL-8 gene expression
Quantitative reverse transcription polymerase chain
reaction (qRT-PCR) was used to determine the effect of
LCM on IL-8 gene transcription. Since it was previously
shown that LCM of LS-B37 and LS-B60 did not sup-
press IL-8 transcription after co-incubation with AGS
cells for 4 h [26], the suppressive effect of these LCM
was tested further at various time points. H. pylori-stim-
ulated AGS cells were treated with LCM for 2, 4 and 6 h
prior to total RNA isolation. IL-8 gene expression at 2 h,
relative to gapdh, was significantly down-regulated ap-
proximately 0.4 and 0.3 fold with the treatment of LCM
from LS-B37 (p < 0.0001) and LS-B60 (p < 0.0001),
respectively. Unexpectedly, LCM from LS-B37 also


















































Fig. 1 Specific strains of gastric-derived L. salivarius suppress IL-8
production by H. pylori-induced AGS cells. LCM from three strains of
L. salivarius were tested for the ability to suppress IL-8 production
from AGS cells stimulated by H. pylori. AGS cells were incubated with
LCM in the presence or absence of H. pylori ATCC43504 for 24 h and
IL-8 secretion was measured by ELISA. The results were from three
independent experiments in triplicate and expressed as the mean ±
SEM, ***p < 0.001 as compared to medium control
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fold (p < 0.0007) at 4 h. In addition, LCM from both
strains did not affect IL-8 gene expression at 6 h (Fig. 2,
Additional file 2).
Secreted factors from L. salivarius strains B37 and B60
inhibit NF-κB activation
H. pylori induces various signaling pathways resulting in
phosphorylation of transcription factors NF-κB and acti-
vator protein-1 (AP-1) and downstream transcription of
IL-8 in gastric epithelial cells [27–29]. To determine the
effect of immunomodulatory substances produced by LS-
B37 and LS-B60 on the activation of NF-κB and AP-1, the
concentrations of phosphorylated subunits p65 (p-NF-κB
p65) and c-Jun (p-c-Jun) were assayed by Western blot. H.
pylori-stimulated AGS cells were treated with LCM from
either LS-B37 or LS-B60 for 0.25, 0.5, 1, 2 and 3 h. Treat-
ment of LCM from LS-B37 decreased the concentration
of p-NF-κB p65 at 15 min (28.52 %, p < 0.01, Fig. 3,
Additional file 3) and no significant effects were found at
other time points. Treatment with LS-B60 LCM
resulted in a significant decrease in p-NF-κB p65
(38.29 %, p < 0.01, Fig. 3, Additional file 3) only at
2 h. In contrast, LCM from both strains did not suppress
p-c-Jun at any studied time point (data not shown).
The immunomodulatory substances in LCM of L. salivarius
strains B37 and B60 are heat-stable and larger than
100 kDa
Heat treatment and size fractionation of LCM were per-
formed in order to characterize the physical nature of
the IL-8 inhibitory substances. LCM from LS-B37 and
LS-B60 were heated to 100 °C for 0.25, 0.5, 1 and 2 h
and assayed for IL-8 suppression by an enzyme-linked im-
munosorbent assay (ELISA). Heat-treated LCM of LS-B37
and LS-B60 at all time retained inhibitory activity of H. pyl-
ori-induced IL-8 production in AGS cells when compared
with MRS control (p < 0.001, Fig. 4a, Additional file 4).
Amicon® Centrifugal Filters (3 kDa, 50 kDa and
100 kDa) were used to size fractionate LS-B37 and LS-
B60 LCM and each fraction was tested for inhibitory
activity on H. pylori-induced IL-8 production. Fractions
containing substances >100 kDa significantly suppressed
IL-8 production as compared with MRS control (p < 0.001),
whereas those containing substances <3 kDa, <50 kDa, and
<100 kDa did not suppress H. pylori-induced IL-8 produc-
tion (Fig. 4b, Additional file 5).
Enzyme sensitivity of the immunomodulatory substances
in LCM of L. salivarius strains B37 and B60 indicates
differences in chemical nature
To determine the chemical nature of IL-8 inhibitory
substances in LS-B37 and LS-B60 LCM, treatments with
α-amylase, lipase, proteinase K, trypsin, and lysozyme
were performed. LCM from LS-B37 and LS-B60 were
incubated with each of these enzymes for 6 h and then
tested for H. pylori-induced IL-8 production. Treatment
of LS-B37 LCM with α-amylase abolished IL-8 suppres-
sion as compared to media control ( p > 0.066) and non-
treated LCM (>4 fold change, p < 0.0001), while treatment
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Fig. 2 L. salivarius-produced factors suppress IL-8 transcription in AGS cells. IL-8 gene expression was determined in H. pylori-induced AGS cells
after incubation with medium control or LCM from L. salivarius. Gene expression was examined using qRT-PCR with primers specific to IL-8 and
GAPDH transcripts. Quantitative gene expression data were normalized to housekeeping gene, GAPDH. The experiments were performed three
times independently, each in triplicate. Fold change of IL-8 gene expression was calculated in relative to medium control, and results represent
the mean ± SEM, ***p < 0.001 as compared to medium control
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affect IL-8 suppression (Fig. 5, Additional file 6). Treat-
ment of LS-B60 LCM with either α-amylase or proteinase
K resulted in the loss of IL-8 inhibitory activity as com-
pared to media control (p > 0.1003 and p > 0.0972, respect-
ively) and non-treated LCM (>4 fold change, p < 0.001
and p < 0.001, respectively). The treatment with lipase or
trypsin affected IL-8 suppression of LS-B60 LCM by
4-fold as compared to non-treated LCM (p < 0.001
and p < 0.001, respectively) although LS-B60 LCM
retained some suppression of IL-8 production that
was statistically different from media control (p < 0.01
and p < 0.05, respectively). No effect on IL-8 suppres-
sion was detected when LS-B60 LCM was treated
with lysozyme (Fig. 5, Additional file 6). These results
suggest that the inhibitory substance of LS-B37 is polysac-
charide, whereas the one of LS-B60 is complex consisting
of components of polysaccharide, protein and lipid. On
the other hand, LS-B60 may produce multiple immuno-
modulating substances like glycoproteins or lipoproteins.
As lysozyme had no effect on IL-8 suppression by LCM
from either strain, the peptidoglycan of these lactobacilli is
most likely not involved.
Discussion
Persistent colonization of H. pylori results in chronic in-
flammation which predisposes infected people to severe
peptic ulcer disease and gastric cancer [30]. Among sev-
eral factors, pro-inflammatory cytokines and chemokines
are the main mediators of mucosal inflammation and
damage [4, 5]. IL-8 is a key chemokine in neutrophil
infiltration [7, 8] that is associated with disease severity
[14, 16] and considered a potential prognostic and pre-
dictive cancer biomarker [31]. In fact, whole genome
analysis of H. pylori-exposed AGS gastric epithelial cells
revealed that after a 3 h exposure IL-8 is the single most
up-regulated gene among > 38,000 genes tested [32].
Specific strains of Lactobacillus have been shown to
diminish H. pylori-induced IL-8 production in vitro and
in vivo [23–25]. We have identified anti-inflammatory
Lactobacillus spp. which suppress IL-8 secretion by H.
pylori-induced AGS cells. Among these strains, it is in-
teresting that L. salivarius strains B37 and B60 did not
suppress IL-8 gene transcription at 4 h of co-culture
[26]. It was previously reported that L. casei VSL#3 sup-
pressed TNF-induced secretion of the T-cell chemokine
interferon-inducible protein (IP-10) secretion by Mode-
K intestinal epithelial cells without inhibiting IP-10 gene
transcription. Study of the mechanism underlying this
observation revealed that L. casei impairs vesicular path-
ways important for the secretion of IP-10 and the
chemokine is subsequently degraded [33]. In an attempt
to characterize the mechanism involved in the suppres-
sion of IL-8 secretion by LS-B37 and LS-B60, we first in-
vestigated the effect on IL-8 gene expression by LCM of
LS-B37 and LS-B60 at various time points. Our data
demonstrated that both LCM reduced IL-8 gene expres-
sion as early as a 2 h co-culture and the reduction by
LS-B37 LCM continued at 4 h. Interference with IL-8
gene expression by probiotic microbes has been reported








































Fig. 3 L. salivarius strains suppress H. pylori-activated NF-κB in AGS gastric epithelial cells. H. pylori-stimulated AGS cells were incubated with
medium control or LCM of LS-B37 and LS-B60 for 0.25, 0.5, 1, 2, and 3 h. Concentration of activated NF-κB were measured by Western blot analysis
using antibodies to p-NF-κB p65 and NF-κB p65. Relative protein concentration was quantified by densitometry and activated transcription factor (p-
NF-κB p65 [Ser 536]) was normalized to non-activated counterpart (NF-κB p65). The results were from three independent experiments and expressed
as the mean ± SEM, **p < 0.01 as compared to medium control
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OLL2716 (LG21) inhibited H. pylori-induced IL-8 gene
expression by MKN45 gastric epithelial cells only at 6 h
of co-culture [25]. On the contrary, Saccharomyces bou-
lardii reduced IL-1β-induced IL-8 mRNA levels in HT-
29 colonic epithelial cells at all time points studied from
0.5 to 4 h [34]. This study also demonstrated that LCM
from LS-B37 and LS-B60 suppressed the activation of
NF-κB at different time points (15 min and 2 h, respect-
ively) but did not interfere with p-c-Jun activation. It has
been demonstrated that IL-8 gene transcription in gas-
tric epithelial cells requires the activation of both NF-κB
and AP-1 [35], and a mutation in the IL-8 gene at the
NF-κB binding site alone results in the inhibition of IL-8
gene expression [35, 36]. Therefore, suppression of only
NF-κB activation by LCM of LS-B37 and LS-B60 should
be sufficient for inhibiting IL-8 production by these
lactobacilli. Anti-inflammatory L. salivarius B101 and L.
rhamnosus B103 were also shown to suppress only p-
NF-κB activated by H. pylori but the suppression oc-
curred at various time points [26].
With an increase in the interest of anti-inflammatory
Lactobacillus for H. pylori treatment, the molecular
nature of immunomodulating substances has been inves-
tigated in Lactobacillus spp. Among several factors
influencing host immune response, exopolysaccharides,
which are extracellular polysaccharides attached to the
bacterial cell surface or secreted into the extracellular
environment, have been recognized to influence immune
signaling [37]. In this study, the IL-8-suppressing sub-
stance in LCM of LS-B37 was a heat-stable, α-amylase
-sensitive factor with a molecular size >100 kDa suggest-
ing the production of an immunomodulatory exopoly-
saccharide by LS-B37. Exopolysaccharides of beneficial
bacteria have long been shown to act as immunomodu-
lating agents and their contributions to immune stimula-






















































Fig. 4 IL-8 suppression by heat-treated and fractionated LCM of L. salivarius. LCM of LS-B37 and LS-B60 were either heat treated (a) or fractionated
by using Amicon centrifugal filter (b) and tested for the suppression of IL-8 production using a Quantikine Human IL-8 Immunoassay. The results
were from three independent experiments in triplicate and expressed as the mean ± SEM, ***p < 0.001 as compared to medium control
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various aspects. Soluble polysaccharides with molecular
weights between 60 and 2460 kDa of Bifidobacterium
adolescentis M101-4 were found to stimulate the prolif-
eration of murine splenocytes, suggesting their immuno-
modulation activity [38]. Polysaccharide-peptidoglycan
complex derived from Lactobacillus casei strain Shirota
inhibited the release of IL-6 in LPS-stimulated large in-
testinal lamina propria mononuclear cells isolated from
mice with chronic colitis and in RAW264.7 cells in vitro
[39]. Pretreatment of exopolysaccharides obtained from
Bifidobacterium longum BCRC 14634 suppressed LPS-
induced cell growth inhibition and release of TNF-α
from J774A.1 macrophages [40]. Exopolysaccharides
with molecular weights ≤ 70 kDa obtained from the
culture medium of Lactobacillus confusus TISTR 1498
were observed to induce the production of nitric oxide
and cytokines TNF-α, IL-1β, IL-6 and IL-10 through the
activation of NF-κB and JNK pathways [41]. In addition,
an exopolysaccaride of Lactobacillus rhamnosus GG
alleviated inflammatory cytokines IL-6, IL-12 and TNF-α
in LPS-induced IPEC-J2 porcine intestinal epithelial cells
at mRNA level by attenuation of MAPK and NF-kB
signaling activations [42].
On the contrary to LS-B37, LS-B60 LCM is sensitive
to α-amylase, lipase, proteinase K and trypsin albeit with
different magnitudes. It is probable that immunomodu-
latory substance(s) in LCM of LS-B60 is complex
consisting of components of polysaccharide, protein and
lipid. However, our result could not exclude the possibil-
ity that LS-B60 produces multiple immunomodulatory
substances such as glycoproteins and lipoproteins.
Bacterial glycoproteins have been identified [43] and
secreted glycoproteins were reported in L. plantarum
WCFS1 [44] and L. rhamnosus GG [45]. Glycoproteins
of L. plantarum WCFS1 are thought to be recognized by
the DC-specific ICAM-3-grabbing non-integrin (DC-
SIGN) receptor and thereby eliciting specific cytokine
production and immune responses in immature human
dendritic cells [44]. Anti-inflammatory activity of cell-
associated glycoprotein was recently reported in L. plan-
tarum L67 for the protection of inflammation caused by
cadmium ion in RAW 264.7 cells by suppressing the ex-
pression of AP-1 (c-Jun and c-Fos), mitogen-activated
protein kinases (ERK, JNK and p38), and inducible nitric
oxide synthase [46]. The immunomodulatory effect of
bacterial lipoprotein (BLP) was also demonstrated in E.
coli Nissle 1917 in that BLP acts like the conditioned
medium in the modulation of T-cell cycle progression
by binding to toll-like receptor-2 which may downregu-
late the expansion of newly recruited T cells into the
mucosa and limit intestinal inflammation [47].
The structure and composition of polysaccharides and
other biological substances are diverse among microbes
and this variation may contribute to the different immu-
nomodulation of host immune responses. Although we












































Fig. 5 Enzyme sensitivity of the immunomodulatory substances in LCM of L. salivarius. Substances in LCM of LS-B37 and LS-B60 were incubated with
enzymes α-amylase, lipase, lysozyme, proteinase K and trypsin and the effect on IL-8 production was tested using a Quantikine Human IL-8 Immunoassay.
The experiments were performed three times in triplicate and the results represented the mean ± SEM, *p< 0.05, **p< 0.01, ***p< 0.001 as compared to
medium control, ###p< 0.001 as compared to non-treated LCM
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our initial characterization suggests the nature of different
anti-inflammatory substances produced by LS-B37and
LS-B60. Further studies are required to determine the
exact molecular nature and function of these substances
in the modulation of immune response to H. pylori
infection.
Conclusions
In this study, we have provided evidence that human
gastric-derived L. salivarius strains B37 and B60 produce
anti-inflammatory substances that suppress IL-8 produc-
tion by H. pylori-induced AGS cells through the attenu-
ation of NF-κB activation. Large, heat-stable bioactive
substances produced by these two strains differ in en-
zymatic sensitivity. The immunomodulatory substance
of L. salivarius B37 is similar to a polysaccharide, while
that of LS-B60 is more structurally complex or includes
multiple components such as glycoprotein and lipopro-
tein. These lactobacilli have potential as probiotics and
their immunomodulatory substances may be pharmaco-
logic agents for treatment of H. pylori-associated diseases.
Methods
Bacterial strains, cell line and culture conditions
Lactobacillus salivarius strains B37, B60, and B78 previ-
ously isolated from gastric biopsies of dyspeptic patients
[48] were obtained from the stock culture maintained at
the Department of Microbiology, Faculty of Medicine,
Chulalongkorn University. Bacterial stock cultures were
stored at −80 °C in deMan Rogosa Sharpe (MRS) broth
(Oxoid, Hampshire, UK) containing 10 % (vol/vol) gly-
cerol. All lactobacilli were cultured on MRS agar in an
anaerobic chamber (Concept Plus, Ruskinn Technology,
UK) (10 % CO2, 10 % H2, and 80 % N2) at 37 °C for
24 h. Helicobacter pylori ATCC 43504 (ATCC, Manas-
sas, VA, USA) was grown on Columbia agar (Oxoid,
England) supplemented with 7 % (v/v) horse serum
(Gibco New Zealand Ltd, Auckland, New Zealand) and
7 % (v/v) sheep blood at 37 °C for 48 h under microaero-
philic conditions ( 6–12 % O2, 5–8 % CO2) using gas
generation sachets (Anaero Pack-MicroAero, Mitsubishi
Gas Chemical, Japan) AGS human gastric adenocarcin-
oma epithelial cells (ATCC CRL-1739) obtained from
the American Type Culture Collection (Manassas, VA,
USA) were cultured as a monolayer (>80 % confluence)
in RPMI 1640 medium supplemented with 10 % (v/v)
heat-inactivated fetal bovine serum (Gibco-Invitrogen,
USA) at 37 °C and 5 % CO2 atmosphere for 48 h. AGS
cells were passaged every 2–3 days. Adherent cells were
detached from the flask with 0.25 % (v/v) trypsin in
1 mM EDTA (Gibco-Invitrogen, USA), resuspended in
fresh medium and used in the co-culture assay.
Preparation of Lactobacillus conditioned media
Lactobacillus-conditioned media (LCM) were prepared
as previously described [49]. L. salivarius strains were
first cultured for 24 h, then adjusted to an OD600 of 0.1
in MRS broth and incubated anaerobically for 48 h. Cell
free supernatants were collected by centrifugation at
4000 × g for 10 min at 4 °C, filtered through a 0.22 μm
membrane filter (Minisart, Sartorius Stedim Biotech
GmbH, Goettingen, Germany) and concentrated by
speed vacuum drying for 3 h. (Savant instruments,
Farmingdale, NY). Cell-free concentrated pellets were
resuspended in an equal volume of RPMI 1640 medium
(Gibco-Invitrogen, Carlsbad, CA, USA) and stored at
−20 °C until further use.
Effect of LCM treatment on IL-8 production in the co-
culture assay
AGS gastric epithelial cells were treated with LCM and
co-cultured with H. pylori to induce IL-8 production as
previously described [50]. AGS cells (2.0 × 104 cells/well)
were pre-incubated as described above for 24 h. The cul-
ture supernatant was replaced with fresh RPMI medium
containing either 5 % (v/v) LCM alone or in combin-
ation with viable H. pylori ATCC 43504 (6.0 × 106 CFU/
well) and incubated under 5 % CO2 at 37 °C for 24 h.
Cell culture supernatants were collected by centrifuga-
tion at 125 × g for 7 min at 4 °C. IL-8 concentrations in
culture supernatants were determined using the Quanti-
kine Human IL-8 Immunoassay Kit (R&D Systems,
Minneapolis, MN) according to the manufacturer’s in-
structions. All experiments were tested at least three
times in triplicate.
Analysis of IL-8 gene expression by qRT-PCR
The effects of LCM on the transcription of IL-8 in H.
pylori-treated AGS epithelial cells were determined by
qRT- PCR as previously described [26, 51] with minor
modifications. AGS cells (5 × 105cells/well) were cul-
tured in a 24-well plate as described above and treated
with viable H. pylori ATCC 43503 (1.5 × 108 CFU/well)
with or without LCM (5 % v/v) for 2, 4, and 6 h. Cell
culture supernatants were removed by centrifugation
and total RNA of treated AGS cells was extracted with
TRIzol reagent (Invitrogen, USA) according to the man-
ufacturer’s instructions. Complementary DNA (cDNA)
was reverse transcribed from 10 ng total RNA using the
SuperScript® VILOTM cDNA Synthesis kit (Invitrogen,
USA), and qPCR was performed in a LightCycler® 2.0
(Roche, Germany) for 45 cycles of: 10 s at 95 °C, 10 s at
65 °C, and 25 s at 72 °C. The following primers were
used to amplify cDNA fragments: IL-8 forward primer
(5′-ACACTGCGCCAACACAGAAATTA-3′), and IL-8
reverse primer (5′-TTTGCTTGAAGTTTCACTGGCAT
C-3′); Human glyceraldehyde-3-phosphate dehydrogenase
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(GAPDH) forward primer (5′-GCACCGTCAAGGCTG
AGAAC-3′), and GAPDH reverse primer (5′-ATGG
TGGTGAAGACGCCAGT-3′). IL-8 gene expression, rela-
tive to GAPDH, was calculated according to the 2-ΔΔCp
method [52].
Examination of cell signaling pathways by quantitative
western blot
The modulation of signaling pathways by LCM was ex-
amined by western blot as previously described with
minor modifications [26, 28]. AGS cells (2.0 × 106cells/
well) were cultured in a 6-well plate as described above.
AGS cells were stimulated with H. pylori ATCC 43504
(6.0 × 108 CFU/well) in the presence or absence of LCM
(5 % v/v) for 0.25, 0.5, 1, 2, and 3 h. Proteins were ex-
tracted from whole cell lysates of AGS-treated cells
using Mammalian Protein Extraction Reagent (M-PER,
Pierce Biotechnology, Illinois, USA) supplemented with
Halt protease and phosphatase inhibitors (Pierce Biotech-
nology, Illinois, USA) according to the manufacturer’s
instructions. Protein concentrations from cell lysates were
determined using the Pierce® BCA protein assay kit
(Pierce Biotechnology, Illinois, USA). Cell extracts were
fractionated by 10 % sodium dodecyl sulfate polyacryl-
amide gel electrophoresis (SDS-PAGE), transferred onto
PVDF membranes (Bio-Rad, Philadelphia, USA) and
blocked with 10 % non-fat milk in TBST (50 mM Tris,
pH 7.5, 150 mM NaCl, 0.05 % Tween 20). Blocked mem-
branes were incubated with mouse antibodies against NF-
κB (p65), phospho-NF-κB (p65), c-Jun, phospho-c-Jun
(Santa Cruz Biotechnology, California, USA) and β-actin
(Cell signaling Technology, Inc, MA, USA), washed with
TBST and incubated with horseradish peroxidase-labeled
goat anti-mouse secondary antibodies for 1 h. Peroxidase
signals were measured and imaged by ChemiDoc™ XRS
(Bio-Rad, Philadelphia, USA). Densitometric analyses for
protein quantification were carried out using ImageJ
1.45 s software.
Characterization of IL-8 suppressing substance(s) in LCM
The properties of IL-8-suppressing substances produced
by L. salivarius strains were tested for heat stability, size
estimation, and enzyme sensitivity. Heat stability was
assessed by heating LCM to 100 °C for 0.25, 0.5, 1, and
2 h. The sizes of active factors present in LCM were esti-
mated by 3 kDa, 50 kDa and 100 kDa Amicon® Ultra-4
Centrifugal Filters (Millipore Ireland B.V.,Tullagreen,
Carrigtwohill, County Cork, Ireland) according to the
manufacturer’s instruction. Enzyme sensitivity of LCM
was tested by incubation with various enzymes: α-
amylase in 20 mM sodium acetate, 7 mM sodium
chloride (pH 6.9); lipase and lysozyme each in 50 mM
Tris–HCl (pH 7.2); proteinase K and trypsin each in
50 mM Tris–HCl (pH 7.5–7.6). Each enzyme (Sigma,
USA) was used at a final concentration of 1 mg/mL and
incubated at 37 °C for 6 h, except for amylase and lyso-
zyme which were incubated at 25 °C. Enzymes were inac-
tivated by heating each enzyme-treated LCM at100 °C for
10 min. All treated samples were tested for IL-8 suppres-
sive activity in the co-culture assay described above.
Statistical analysis
All experiments were performed three times each in
triplicate and the results were reported as mean ± stand-
ard deviation (SD) or standard error of mean (SEM).
The data were analyzed in GraphPad Prism 5 using the
unpaired t test with one-tailed distribution and consid-
ered statistically significant at a p-value ≤ 0.05, unless
otherwise stated.
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showing the effect of heat treatment on LCM of LS-B37; Table S2B Raw
data used to generate Fig. 4a showing the effect of heat treatment on
LCM of LS-B60. (DOCX 20 kb)
Additional file 5: Table S3A. Raw data used to generate Fig. 4b
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